How bacteria initiate inflammation: Aspects of the emerging story

Current Opinion in Microbiology

Volumn 1, Issue 1, 1998, Pages 43-48

  Hersh, David ^a   Weiss, Jerrold ^a   Zychlinsky, Arturo ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

BACTERIAL DNA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

APOPTOSIS; BACTERIAL INFECTION; BACTERIUM; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; INFLAMMATION; PATHOGENICITY; PATHOPHYSIOLOGY; REVIEW;

APOPTOSIS; BACTERIA; BACTERIAL INFECTIONS; DNA, BACTERIAL; HUMANS; INFLAMMATION; INTERLEUKIN-8; LIPOPOLYSACCHARIDES;

EID: 0031987914     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80141-0     Document Type: Article

References (53)

1. Henderson B, Poole S, Wilson M: Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996, 60:316-341. A comprehensive review of bacterial products, termed 'modulins', that induce cytokine production by host cells. It provides an introductory summary of particular cylokines' biological actions and an extended section on lipolysaccharide structure and signalling. Most importantly, it underscores the diversity of the modulins and sets a framework for approaching discussion of cytokine induction by bacteria.
2. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995, 13:437-457.
3. Stevens DL: Superantigens: their role in infectious diseases. Immunol Invest 1997, 26:275-281.
4. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989, 84:1045-1049.
5. Rainger GE, Fisher AC, Shearman C, Nash GB: Adhesion of flowing neutrophils to cultured endothelial cells after hypoxia and reoxygenation in vitro. Am J Physiol 1995, 263:H1398-H1406.
6. Smart SJ, Casale TB: Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am J Respir Cell Mol Biol 1993, 9:489-495.
7. Willems J, Joniau M, Cinque S, Van Damme J: Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 1989, 67:540-542.
8. Imamura S, Matsukawa A, Ohkawara S, Kagayama M, Yoshinaga M: Involvement of tumor necrosis factor-a, interleukin-1β, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local Schwartzman reaction. Pathol Int 1997, 47:16-24. The elucidation of the temporal roles of tumor necrosis factor-α (TNF-α), interleukin (1L)-1β, IL-1 receptor antagonist (ra), and IL-8 in the development of pulmonary inflammation following lipopolysaccharide (LPS)-induced lung injury in mice uncovered a chain of events which fit existing in vitro results. Not surprisingly, TNF-a was the first cytokine whose levels became elevated, followed shortly thereafter by concomitant increases in IL-1β and IL-8 levels and neutrophilic infiltration. Interestingly, the ratio of IL-1ra to IL-1β dropped at the onset of inflammation and later recovered and ultimately exceeded resting levels during resolution of the inflammatory process. The balance between these two factors may serve as a signal, with excessive levels of IL-1ra leading to a downregulation of inflammatory events, thereby preventing destructive inflammation. Production kinetics suggest that TNF-α triggers the release of IL-1β and IL-8 which act to enhance neutrophil recruitment and activation.
9. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K: Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 1997, 76:375-384. How important is interleukin (IL)-8? According to results obtained from a rabbit lung injury model intended to reproduce acute respiratory distress syndrome, IL-8 activity is critical for the development of inflammatory findings. Systemic lipopolysaccharide (LPS) challenge following intratracheal instillation of heat-killed streptococci led to elevated IL-8 levels and severe pulmonary inflammation. Pathologic changes were almost completely inhibited by pretreatment with anti-IL-8 antibodies. Clearly, in this model, IL-8 activity occupies a critical position in the chain of inflammatory events.
10. Yao L, Lowy FD, Berman JW: Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells. Infect Immun 1997, 64:3407-3409.
11. Massion PP, Hebert CA, Leong S, Chan B, Inoue H, Grattan K, Sheppard D, Nadel JA: Staphylococcus aureus stimulates neutrophil recruitment by stimulating interleukin-8 production in dog trachea. Am J Physiol 1995, 268:L85-L94.
12. Miller FJ, Nagao S, Carr FK, Noble JM, Cohen AB: Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflammation Res 1996, 45:386-392.
13. Miller EJ, Cohen AB, Peterson BT: Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflammation Res 1996, 45:393-397.
14. Soell M, Diab M, Haan-Archipoff G, Beretz A, Herbelin C, Poutrel B: Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun 1995, 63:1380-1386.
15. Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, VanOtteren GM, Strieter RM: Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun 1994, 62:119-125.
16. Vernier A, Diab M, Soell M, Haan-Archipoff G, Beretz A, Wachsmann D, Klein J-P: Cytokine production by human epithelial and endothelial cells following exposure to oral viridans streptococci involves lectin interactions between bacteria and cell surface receptors. Infect Immun 1997, 64:3016-3022.
17. DiMango E, Zar HJ, Bryan R, Prince A: Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995, 96:2204-2210.
18. Oishi K, Sar B, Wada A, Hidaka Y, Matsumoto S, Amano H, Sonoda F, Kobayashi S, Hirayama T, Nagatake T, Matsushima K: Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells. Infect Immun 1997, 65:2648-2655. An interleukin (IL)-8 inducing activity from P. aeruginosa sonicates was identified as the periplasmic enzyme nitrite reductase. Interestingly, the enzyme's ability to induce human alveolar macrophages to produce tumor necrosis factor -α, IL-1β, and IL-8 is not dependent on its enzymatic activity; rather, a direct interaction with host cells has been postulated as the signal.
19. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990, 161:626-633.
20. Van Der Hulst RWM, Tytgat GNJ: Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996, 220:10-18.
21. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, Primrose JN, Lindley IJD: Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994, 47:61-66.
22. Fan X-G, Chua A, Fan X-J, Keeling PWN: Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995, 48:133-136.
23. Zhang QB, Dawodu JB, Husain A, Etolhi G, Gemmell CG, Russell Rl: Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci 1997, 92: 69-73.
24. Fujiwara Y, Arakawa T, Fukuda T, Sasaki E, Nakagawa K, Fujiwara K1 Higuchi K, Kobayashi K, Tarnawski A: Interleukin-8 stimulates leukocyte migration across a monolayer of cultured rabbit gastric epithelial cells. Dig Dis Sci 1997, 42:1210-1215.
25. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 1997, 65:3218-3224. Intimate contact between viable, intact H. pylori and a gastric cancer derived cell line was necessary for the induction of interleukin (IL)-8 production. Lipopolysaccharide and CD14 were not involved. The bacterial signal is transduced through a tyrosine kinase activity, leading to the activation of the transcription factors NF-κB and AP-1 and their promotion of IL-8 gene expression.
26. Tanaka C, Kamata H, Takeshita H, Yagisawa H, Hirata H: Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF-κ B and AP-1 in human astrocytoma U373 cells. Biochem Biophys Res Commun 1997, 232:568-573.
27. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365. An excellent review on the current mechanistic models for Fas- and tumor necrosis factor-induced apoptosis which touches on the triggers, modulators, and effector molecules involved. The caspase family of proteases, of which interleukin-β converting enzyme is the founding member, is examined in detail.
28. Rowan S, Fisher DE: Mechanisms of apoptotic cell death. Leukemia 1997, 11:457-465.
29. Chen Y, Zychlinsky A: Apoptosis induced by bacterial pathogens. Microb Pathog 1994, 17:203-212.
30. Camp V, Martin P: The role of macrophages in clearing programmed cell death in the developing kidney. Anat Embryol 1996, 194:341-348.
31. Zychlinsky A, Sansonetti PJ: Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol 1997, 5:201-204.
32. Wassef JS, Keren DF, Mailloux JL: Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. Infect Immun 1989, 57:858-863.
33. Perdomo OJJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P, Sansonetti PJ: Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med 1994, 180:1307-1319.
34. Menard R, Sansonetti PJ, Parsot C: Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol 1993, 175:5899-5906.
35. Zychlinsky A, Prevost MC, Sansonetti PJ: Shigella flexneri induces apoptosis in infected macrophages. Nature 1992, 358:167-168.
36. Chen Y, Smith MR, Thirumalai K, Zychlinsky A: A bacterial invasin induces macrophage apoptosis by binding directly to ICE EMBO J 1996, 15:3853-3860.
37. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY: Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J Biol Chem 1988, 263:9437-9442.
38. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA: Identification of a monocyte specific pre-interleukin 1β convertase activity. Proc Natl Acad Sci USA 1989, 86:5227-5231.
39. Zychlinsky A, Fitting C, Cavaillon J-M, Sansonetti PJ: Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest 1994, 94:1328-1332.
40. Sansonetti PJ, Arondel J, Cavaillon J-M, Huerre M: Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest 1995, 96:884-892.
41. Mandic-Mulec I, Weiss J, Zychlinsky A: Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun 1997, 65:110-115.
42. Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T, Sudo T et al.: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984, 72:955-962.
43. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T: Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 1992, 148:4072-4076.
44. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman GJ, Lotz M, Carson DA, Raz E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996, 273:352-354.
45. Krieg A, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
46. Yamamoto T, Yamamoto S, Kataoka T, Tokunaga T: Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol Immunol 1994, 38:831-836.
47. + T cells were also stimulated in vivo and in vitro to secrete proinflammatory cytokines. Significantly, an optimized sequence for CpG in bacterial DNA motifs in bacterial DNA was determined.
48. Cowdery JS, Chace JH, Yi A-K, Krieg AM: Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996, 156:4570-4575. Treating mice with intravenous E. coli DNA and a sublethal dose of lipopolysaccharide (LPS) resulted in significant increases in peak levels of cytokines and in mortality. Apparently, the bacterial DNA potentiates the effects of LPS. The authors suggest that priming of the system, with increased levels of interferon-γ from natural killer cells in response to bacterial DNA, accounts for the difference. This is another example of how bacterial DNA can act as a co-stimulatory molecule and alter the immune response.
49. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxyribonucleotides and bacterial DNA. J Immunol 1996, 157:1840-1845.
50. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi A-K, Krieg AM: CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract J Clin Invest 1997, 100:68-73. A role for bacterial DNA in pulmonary inflammation was demonstrated by the intratracheal instillation in mice of unmethylated CpG motif containing bacterial DNA and oligonucleotides. Lavage fluid from the lower respiratory tract of these animals contained significantly elevated levels of cellular infiltrate and proinflammatory cytokines as compared with controls. The authors suggest relevance to human disease by showing that bacterial DNA isolated from the sputum of cystic fibrosis patients yields similar results.
51. Sparwasser T, Miethke T, Lipford G, Borschert K, Häcker H, Heeg K, Wagner H: Bacterial DNA causes septic shock. Nature 1997, 386:336-337. The in vivo systemic effects of bacterial DNA and CpG motif containing synthetic oligonucleotides were explored following intraperitoneal injection in mice. Experiments utilizing high concentrations of DNA were similar in kinetics and magnitude to experiments utilizing lipopolysaccharide administration, including, under certain conditions, the development of lethal shock secondary to tumor necrosis factor-α production. The data suggest a possible role of bacterial DNA in septic shock.
52. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213.
53. Katz SS, Chen K, Chen S, Doerfler ME, Elsbach P, Weiss J: Potent CD14-mediated signalling of human leukocytes by Esherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect Immun 1996, 64:3592-3600.